BRUKER CORPORATION (NASDAQ: BRKR)

BRUKER CORPORATION

NASDAQ: BRKR (Bruker Corporation)

Last update: 11 Oct, 12:19PM

64.40

0.67 (1.05%)

Add to watchlist

Previous Close	63.73
Open	63.60
Volume	775,746
Avg. Volume (3M)	1,102,684
Market Cap	9,749,774,336

Price / Earnings (TTM)	26.95
Price / Earnings (Forward)	23.15
Price / Sales	2.64
Price / Book	4.85

52 Weeks Range	53.79 (-16%) — 94.86 (47%)
Earnings Date	31 Oct 2024 - 4 Nov 2024
TTM Dividend Yield	0.23%

Market Trend

		Short Term	Medium Term
Industry	Medical Devices (US)	Mixed	Mixed
	Medical Devices (Global)	Mixed	Mixed
Stock	Bruker Corporation	Bearish	Bullish

AIStockmoo Score

0.3

Analyst Consensus	-0.5
Insider Activity	NA
Price Volatility	1.0
Technical Moving Averages	1.0
Technical Oscillators	-0.5
Average	0.25

Similar Stocks

Stock	Market Cap	DY	P/E (TTM)	P/B
BRKR	10 B	0.23%	26.95	4.85
MASI	9 B	-	117.72	6.37
NVCR	3 B	-	-	9.45
LIVN	3 B	-	-	2.07
TNDM	2 B	-	-	9.19
ESTA	1 B	-	-	40.45

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
Sector	Healthcare
Industry	Medical Devices
Investment Style	Small Core
% Held by Insiders	31.92%
% Held by Institutions	79.87%

52 Weeks Range	53.79 (-16%) — 94.86 (47%)
Price Target Range	60.00 (-6%) — 80.00 (24%)
High	80.00 (B of A Securities, 24.22%)	Buy
Median	71.00 (10.25%)
Low	60.00 (Goldman Sachs, -6.83%)	Hold
Average	70.88 (10.06%)
Total	5 Buy, 3 Hold
Avg. Price @ Call	58.43

Firm	Date	Target Price	Call	Price @ Call
Guggenheim	19 Dec 2024	72.00 (11.80%)	Buy	55.29
B of A Securities	13 Dec 2024	80.00 (24.22%)	Buy	57.73
UBS	10 Dec 2024	66.00 (2.48%)	Hold	59.98
Goldman Sachs	05 Dec 2024	60.00 (-6.83%)	Hold	58.48
Barclays	06 Nov 2024	69.00 (7.14%)	Buy	58.98
Barclays	15 Oct 2024	75.00 (16.46%)	Buy	63.11
Citigroup	06 Nov 2024	75.00 (16.46%)	Buy	58.98
TD Cowen	06 Nov 2024	70.00 (8.70%)	Hold	58.98
Wells Fargo	06 Nov 2024	75.00 (16.46%)	Buy	58.98

No data within this time range.

Date	Type	Details
20 Dec 2024	Announcement	Bruker Announces 1.2 GHz NMR Spectrometer at Swiss High-field NMR Facility
02 Dec 2024	Announcement	Bruker Introduces Dimension Nexus™ Atomic Force Microscope
18 Nov 2024	Announcement	Bruker Announces Quarterly Dividend
12 Nov 2024	Announcement	Dragonfly Energy and Bruker Partner to Accelerate Battery Technology Development
12 Nov 2024	Announcement	Bruker Corporation to Present at Upcoming Investor Conferences
08 Nov 2024	Announcement	Bruker Announces EpicIFTM, Revolutionary Fluorescence Signal Removal Technology, Transforming CellScape Spatial Proteomics Platform
05 Nov 2024	Announcement	Bruker Reports Third Quarter 2024 Financial Results
28 Oct 2024	Announcement	Bruker Announces Date and Time of Third Quarter 2024 Earnings Release and Webcast
21 Oct 2024	Announcement	Bruker Announces One-Hundred Dollar, Deep, High-Accuracy Plasma Proteome; Advances Glycoproteomics and Metaproteomics
17 Oct 2024	Announcement	European Unified Patent Court Rules in Favor of Bruker and NanoString, Invalidating Patent Asserted By 10x Genomics against NanoString’s CosMx SMI Products
11 Oct 2024	Announcement	Bruker Announces Formation of New Bruker Spatial Biology Division
07 Oct 2024	Announcement	Bruker Introduces Innovative Neuroscience Research Solution with High-Speed OptoVolt Voltage Imaging
02 Oct 2024	Announcement	Bruker Acquires Dynamic Biosensors, a Pioneer of Single-Cell Interaction Cytometry Systems for Drug Discovery
Show more

TTM Dividend Yield	0.23%
5Y Average Dividend Yield	0.27%
Payout Ratio	9.66%
Expected Next Dividend Payment	Mar 2025

Ex Date	Announcement Date	Payment Date	Details
30 Aug 2024	08 Aug 2024	16 Sep 2024	0.05 Cash
03 Jun 2024	14 May 2024	17 Jun 2024	0.05 Cash
29 Feb 2024	15 Feb 2024	15 Mar 2024	0.05 Cash
30 Nov 2023	17 Nov 2023	15 Dec 2023	0.05 Cash
31 Aug 2023	09 Aug 2023	15 Sep 2023	0.05 Cash
31 May 2023	11 May 2023	16 Jun 2023	0.05 Cash
28 Feb 2023	16 Feb 2023	17 Mar 2023	0.05 Cash
30 Nov 2022	10 Nov 2022	16 Dec 2022	0.05 Cash
31 Aug 2022	11 Aug 2022	16 Sep 2022	0.05 Cash
31 May 2022	13 May 2022	17 Jun 2022	0.05 Cash
28 Feb 2022	17 Feb 2022	18 Mar 2022	0.05 Cash
30 Nov 2021	11 Nov 2021	17 Dec 2021	0.04 Cash
31 Aug 2021	05 Aug 2021	17 Sep 2021	0.04 Cash
28 May 2021	12 May 2021	18 Jun 2021	0.04 Cash
04 Mar 2021	17 Feb 2021	19 Mar 2021	0.04 Cash
30 Nov 2020	11 Nov 2020	18 Dec 2020	0.04 Cash
31 Aug 2020	06 Aug 2020	18 Sep 2020	0.04 Cash
29 May 2020	12 May 2020	19 Jun 2020	0.04 Cash
06 Mar 2020	-	20 Mar 2020	0.04 Cash
29 Nov 2019	-	20 Dec 2019	0.04 Cash
30 Aug 2019	-	20 Sep 2019	0.04 Cash
31 May 2019	-	21 Jun 2019	0.04 Cash
04 Mar 2019	-	22 Mar 2019	0.04 Cash
30 Nov 2018	-	21 Dec 2018	0.04 Cash
31 Aug 2018	-	21 Sep 2018	0.04 Cash
01 Jun 2018	-	22 Jun 2018	0.04 Cash
05 Mar 2018	-	23 Mar 2018	0.04 Cash
01 Dec 2017	-	22 Dec 2017	0.04 Cash
31 Aug 2017	-	22 Sep 2017	0.04 Cash
01 Jun 2017	-	23 Jun 2017	0.04 Cash
06 Mar 2017	21 Feb 2017	24 Mar 2017	0.04 Cash
01 Dec 2016	10 Nov 2016	23 Dec 2016	0.04 Cash
01 Sep 2016	-	23 Sep 2016	0.04 Cash
02 Jun 2016	13 May 2016	24 Jun 2016	0.04 Cash
02 Mar 2016	-	24 Mar 2016	0.04 Cash
Show more

Annual Dividend Yield

Year	Annual Dividend ($)	Frequency/Year	Yield %
2024	0.150	3	0.23
2023	0.200	4	0.27
2022	0.200	4	0.29
2021	0.160	4	0.19
2020	0.160	4	0.30
2019	0.160	4	0.31
2018	0.160	4	0.54
2017	0.160	4	0.47
2016	0.160	4	0.76
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

Realized Profit	-
Unrealized Profit	-
Dividend Received 2024	-
Total Profit	-
Avg. Return	-
Quantity (Buy)	-
Avg. Price (Buy)	-
Quantity (Sold)	-
Avg. Price (Sold)	-

No stocks matching your criteria

Profit Margin	9.41%
Operating Margin (TTM)	10.00%
Diluted EPS (TTM)	2.07
Quarterly Revenue Growth (YOY)	16.40%
Quarterly Earnings Growth (YOY)	-53.60%

Total Debt/Equity (MRQ)	132.63%
Current Ratio (MRQ)	1.66
Operating Cash Flow (TTM)	266.80 M
Levered Free Cash Flow (TTM)	249.88 M

Return on Assets (TTM)	4.83%
Return on Equity (TTM)	19.73%

Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)